PRODUCT LITERATURE

Once-Daily Mometasone Furoate Nasal Spray: Efficacy and Safety of a New Intranasal Glucocorticoid for Allergic Rhinitis

---

Once-daily mometasone furoate nasal spray (MFNS) is a new intranasal glucocorticoid for the treatment of seasonal allergic rhinitis and perennial rhinitis, and
for the prophylaxis of seasonal allergic rhinitis. This paper reviews key findings from the clinical development program for MFNS, comprising more than 20 clinical trials with more than 6000 patients worldwide

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Modexa
Allergic rhinitis
Mometasone furoate nasal spray
Intranasal Glucocorticoid

Specific Detail Info

CLlNlCAL THEiRAPEUTICSVVOL. 19, NO. 1, 1997

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment